We are live on ! Find out more
Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Portfolio holdings

AUM $59.8B
1-Year Est. Return 29.42%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$38.7B
AUM Growth
+$4.24B
Cap. Flow
+$1.61B
Cap. Flow %
4.15%
Top 10 Hldgs %
23.45%
Holding
2,603
New
262
Increased
1,190
Reduced
917
Closed
122
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTLW icon
2351
Algoma Steel Group Warrant
ASTLW
$164K
$41.1K ﹤0.01%
30,000
QVCGA
2352
DELISTED
QVC Group Inc Series A
QVCGA
$37.9K ﹤0.01%
616
+99
+19% +$5.18K
WOOF icon
2353
Petco
WOOF
$785M
$37.6K ﹤0.01%
16,512
+78
+0.5% +$198
LEXX icon
2354
Lexaria Bioscience
LEXX
$8.86M
$37.5K ﹤0.01%
+688
New +$26.3K
ULTA icon
2355
PUT
Ulta Beauty
ULTA
$23.6B
$37.4K ﹤0.01%
1,800
SHOP icon
2356
PUT
Shopify
SHOP
$198B
$35.6K ﹤0.01%
+4,000
New +$316K
NVDA icon
2357
CALL
NVIDIA
NVDA
$5.29T
$35.6K ﹤0.01%
1,000
-59,000
-98% -$4.28M
MAIA icon
2358
MAIA Biotechnology
MAIA
$84.5M
$35.2K ﹤0.01%
16,000
+1,200
+8% +$1.8K
QQQ icon
2359
CALL
Invesco QQQ Trust
QQQ
$480B
$34.8K ﹤0.01%
900
ORMP icon
2360
Oramed Pharmaceuticals
ORMP
$175M
$33.3K ﹤0.01%
11,400
-500
-4% -$1.4K
TSLA icon
2361
CALL
Tesla
TSLA
$1.3T
$33.1K ﹤0.01%
1,200
-12,300
-91% -$2.4M
SGMO
2362
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$32.9K ﹤0.01%
49,095
+14,095
+40% +$10.2K
MTNB icon
2363
Matinas BioPharma
MTNB
$1.73M
$32.3K ﹤0.01%
2,387
REAX icon
2364
Real Brokerage
REAX
$464M
$32.2K ﹤0.01%
+10,319
New +$28.3K
FUBO icon
2365
FuboTV Inc
FUBO
$262M
$31.6K ﹤0.01%
1,666
+74
+5% +$1.93K
ESPR
2366
DELISTED
Esperion Therapeutics
ESPR
$31.4K ﹤0.01%
+11,721
New +$28.5K
EVGO icon
2367
EVgo
EVGO
$221M
$30.8K ﹤0.01%
12,268
+2,134
+21% +$5.54K
META icon
2368
PUT
Meta Platforms (Facebook)
META
$1.51T
$29.7K ﹤0.01%
+700
New +$312K
BFLY icon
2369
Butterfly Network
BFLY
$2.59B
$29.2K ﹤0.01%
27,037
+11,946
+79% +$12.8K
CYTH
2370
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$28.4K ﹤0.01%
20,400
+1,887
+10% +$3.12K
CHPT icon
2371
ChargePoint
CHPT
$158M
$28.2K ﹤0.01%
741
+30
+4% +$1.18K
SBEV icon
2372
Splash Beverage Group
SBEV
$2.46M
$27.6K ﹤0.01%
375
-63
-14% -$5.02K
GOOGL icon
2373
PUT
Alphabet (Google) Class A
GOOGL
$4.34T
$27.4K ﹤0.01%
3,800
EW icon
2374
PUT
Edwards Lifesciences
EW
$53.3B
$27K ﹤0.01%
+9,500
New +$798K
NEWP
2375
New Pacific Metals
NEWP
$1.19B
$26.6K ﹤0.01%
+19,886
New +$24.9K

Similar funds

Wealth Enhancement Advisory Services's Q1 2024 Portfolio in Review

As of Q1 2024, Wealth Enhancement Advisory Services held 2,603 positions worth $38.7B, up 12% from $34.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Wealth Enhancement Advisory Services deployed $1.61B of net new capital in Q1 2024, opening 262 new positions and adding to 1,190 existing holdings. Its largest new stake was ALPS Smith Core Plus Bond ETF: 19,926,994 shares worth $511M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street DoubleLine Total Return Tactical ETF, an estimated $409M trimmed.

  • Wealth Enhancement Advisory Services's largest Q1 2024 buy was ALPS Smith Core Plus Bond ETF: 19,926,994 shares worth $511M.
  • Wealth Enhancement Advisory Services added most to JPMorgan US Momentum Factor ETF in Q1 2024, an estimated $377M increase.
  • Wealth Enhancement Advisory Services's biggest Q1 2024 reduction was State Street DoubleLine Total Return Tactical ETF, cutting an estimated $409M.
  • Wealth Enhancement Advisory Services fully exited JPMorgan Short Duration Core Plus ETF in Q1 2024, selling an estimated $26.5M.
  • Wealth Enhancement Advisory Services's ten largest holdings make up 23% of its $38.7B portfolio in Q1 2024.
  • Wealth Enhancement Advisory Services opened 262 new positions and closed 122 in Q1 2024.
  • Wealth Enhancement Advisory Services's portfolio value rose 12% quarter-over-quarter to $38.7B.

Based on Wealth Enhancement Advisory Services's 13F filing for Q1 2024, filed 15 Apr 2024.